Phase II Trial Shows Promise of Repeated Stem Cell Injections for ALS Treatment
Amyotrophic Lateral Sclerosis (ALS) is a degenerative disease that affects motor neurons in the brain and spinal cord, leading to muscle paralysis and death, typically within 3-5 years of onset. Despite two FDA-approved therapies, Riluzole, and Edravarone, which offer limited benefits, there remains no cure for ALS. Considering this, researchers have turned to Mesenchymal Stem…
